[Federal Register Volume 77, Number 58 (Monday, March 26, 2012)]
[Notices]
[Pages 17529-17530]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7184]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Notice of Charter Renewal: Advisory Committee on the Medical Uses 
of Isotopes

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: This notice is to announce the renewal of the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI) for a period of two 
years.

-----------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: The U.S. Nuclear Regulatory Commission (NRC) 
has determined that the renewal of the Charter for the Advisory 
Committee on the Medical Uses of Isotopes for the two year period 
commencing on March 14, 2012 is in the public interest, in connection 
with duties imposed on the Commission by law. This action is being 
taken in accordance with the Federal Advisory Committee Act, after 
consultation with the Committee Management Secretariat, General 
Services Administration.
    The purpose of the ACMUI is to provide advice to NRC on policy and 
technical issues that arise in regulating the medical use of byproduct 
material for diagnosis and therapy. Responsibilities include providing 
guidance and comments on current and proposed NRC regulations and 
regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use;

[[Page 17530]]

and evaluating training and experience of proposed authorized users. 
The members are involved in preliminary discussions of major issues in 
determining the need for changes in NRC policy and regulation to ensure 
the continued safe use of byproduct material. Each member provides 
technical assistance in his/her specific area(s) of expertise, 
particularly with respect to emerging technologies. Members also 
provide guidance as to NRC's role in relation to the responsibilities 
of other Federal agencies as well as of various professional 
organizations and boards.
    Members of this Committee have demonstrated professional 
qualifications and expertise in both scientific and non-scientific 
disciplines including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; nuclear pharmacy; State medical regulation; 
patient's rights and care; health care administration; and Food and 
Drug Administration regulation.

FOR FURTHER INFORMATION CONTACT: Ashley Cockerham, Office of Federal 
and State Materials and Environmental Management Programs, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; Telephone (240) 888-7129; 
email <a href="/cdn-cgi/l/email-protection#0544766d69607c2b466a666e60776d6468456b77662b626a73"><span class="__cf_email__" data-cfemail="e4a5978c88819dcaa78b878f81968c8589a48a9687ca838b92">[email protected]</span></a>.

    Dated: March 19, 2012.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 2012-7184 Filed 3-23-12; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>